Safety and efficacy of secukinumab in psoriasis patients infected with hepatitis B virus: a retrospective study

被引:0
|
作者
Hui Qin
Na Liu
Yifan Hu
Ning Yu
Xuemei Yi
Yunlu Gao
Fujuan Chen
Jun Gu
Yangfeng Ding
Yuling Shi
机构
[1] Tongji University School of Medicine,Department of Dermatology, Shanghai Skin Disease Hospital
[2] Tongji University School of Medicine,Institue of Psoriasis
[3] Tongji University School of Medicine,Department of Dermatology, Shanghai Tenth People’s Hospital
来源
关键词
psoriasis; hepatitis B virus (HBV) infection; China; secukinumab; safety; efficacy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:394 / 400
页数:6
相关论文
共 50 条
  • [1] Safety and efficacy of secukinumab in psoriasis patients infected with hepatitis B virus: a retrospective study
    Qin, Hui
    Liu, Na
    Hu, Yifan
    Yu, Ning
    Yi, Xuemei
    Gao, Yunlu
    Chen, Fujuan
    Gu, Jun
    Ding, Yangfeng
    Shi, Yuling
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2022, 32 (03) : 394 - 400
  • [2] Secukinumab treatment of individuals with psoriasis infected with hepatitis B and/or hepatitis C virus
    Siegel, S. A. R.
    Winthrop, K. L.
    Ehst, B. D.
    Ortega-Loayza, A. G.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S32 - S32
  • [3] EFFICACY AND SAFETY OF SECUKINUMAB IN PATIENTS WITH PSORIASIS
    Su, Q. Y.
    Zhao, B. R.
    Gao, H. J.
    Sun, S. C.
    Luo, J.
    Yu, Q.
    He, P. F.
    Li, X.
    Zhang, S. X.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1791 - 1792
  • [4] Safety of secukinumab in hepatitis B virus
    Bevans, S. L.
    Mayo, T. T.
    Elewski, B. E.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : E120 - E121
  • [5] A retrospective study to assess the efficacy, safety, and drug survival of secukinumab in plaque psoriasis patients in China
    Wang, Yu
    Wang, Xiaohua
    Yu, Yixin
    Yuan, Liyan
    Yu, Xiaoling
    Yang, Bin
    [J]. DERMATOLOGIC THERAPY, 2021, 34 (05)
  • [6] Hepatitis B Virus Reactivation in Patients with Psoriasis on Biologic Therapies: A Retrospective Study
    Ozcelik, Sinan
    Kilic, Fatma Arzu
    [J]. TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, 2020, 14 (03): : 65 - 70
  • [7] Risk of Hepatitis B Virus Reactivation in Patients on Secukinumab for Psoriasis: A Series of 4 Cases
    Moneva-Leniz, L. M.
    Sahuquillo-Torralba, A.
    Vila-Payeras, A.
    Mateu-Puchades, A.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (07): : 612 - 613
  • [8] Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study
    Chiu, Hsien-Yi
    Hui, Rosaline Chung-yee
    Huang, Yu-Huei
    Huang, Ruey-Yun
    Chen, Kai-Lung
    Tsai, Ya-Chu
    Lai, Po-Ju
    Wang, Ting-Shun
    Tsai, Tsen-Fang
    [J]. ACTA DERMATO-VENEREOLOGICA, 2018, 98 (09) : 829 - 834
  • [9] Efficacy of secukinumab in psoriasis and psoriatic arthritis: A retrospective multicentre study
    Ruiz-Villaverde, Ricardo
    Rodriguez-Fernandez-Freire, Lourdes
    Galan-Gutierrez, Manuel
    Martinez-Pilar, Leandro
    [J]. MEDICINA CLINICA, 2020, 154 (09): : 370 - 371
  • [10] Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
    Ribero, Simone
    Licciardello, Matteo
    Quaglino, Pietro
    Dapavo, Paolo
    [J]. CASE REPORTS IN DERMATOLOGY, 2019, 11 : 23 - 28